Stockreport

NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

NeoGenomics, Inc.  (NEO) 
Last neogenomics, inc. earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.neogenomics.com
PDF NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026 FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics [Read more]